Clinical Trials · NCT00002580
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Scottish Cancer Therapy Network
- Enrollment
- 1,000
- Start date
- Jun 1993
- Locations
- 10 sites, United Kingdom
- Primary endpoint
- Study in Breast Cancer